STOCK TITAN

CryoMass Announces Sale of CryoSift Separator™ and License of Its Cryogenic Refinement Technology in Oklahoma Market

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags

CryoMass Technologies Inc. (OTCQB: CRYM) has announced the sale of a CryoSift Separator™ production model to Tribe Collective, with shared usage rights granted to Choctaw Processing in the Oklahoma cannabis market. The deal includes non-exclusive patent license agreements with both companies for at least five years.

The transaction structure combines one-time revenue from equipment sale and recurring processing fees based on biomass volume, with potential recurring revenues exceeding $1,000,000 annually. The sale was facilitated through financing from NEC Financial Services,

This shared-usage model demonstrates CryoMass's ability to create value for multiple operators within competitive markets by enabling cost reductions and improved extraction efficiency. The technology adoption by established operators validates its potential to transform harvest and post-harvest operations while establishing a recurring revenue model for CryoMass.

CryoMass Technologies Inc. (OTCQB: CRYM) ha annunciato la vendita di un modello di produzione del CryoSift Separator™ a Tribe Collective, con diritti di utilizzo condivisi concessi a Choctaw Processing nel mercato della cannabis dell'Oklahoma. L'accordo include contratti di licenza per brevetti non esclusivi con entrambe le aziende per almeno cinque anni.

La struttura della transazione combina ricavi una tantum dalla vendita dell'attrezzatura e commissioni di lavorazione ricorrenti basate sul volume di biomassa, con potenziali ricavi ricorrenti superiori a $1.000.000 all'anno. La vendita è stata facilitata grazie al finanziamento di NEC Financial Services.

Questo modello di utilizzo condiviso dimostra la capacità di CryoMass di creare valore per più operatori all'interno di mercati competitivi, consentendo riduzioni dei costi e migliorando l'efficienza dell'estrazione. L'adozione della tecnologia da parte di operatori affermati convalida il suo potenziale di trasformare le operazioni di raccolta e post-raccolta, stabilendo nel contempo un modello di ricavi ricorrenti per CryoMass.

CryoMass Technologies Inc. (OTCQB: CRYM) ha anunciado la venta de un modelo de producción del CryoSift Separator™ a Tribe Collective, con derechos de uso compartido concedidos a Choctaw Processing en el mercado de cannabis de Oklahoma. El acuerdo incluye contratos de licencia de patente no exclusivos con ambas compañías por un período mínimo de cinco años.

La estructura de la transacción combina ingresos únicos por la venta de equipos y tarifas de procesamiento recurrentes basadas en el volumen de biomasa, con ingresos recurrentes potenciales que superan $1,000,000 anuales. La venta fue facilitada a través de financiamiento de NEC Financial Services.

Este modelo de uso compartido demuestra la capacidad de CryoMass para crear valor para múltiples operadores dentro de mercados competitivos, permitiendo reducciones de costos y mejorando la eficiencia de extracción. La adopción de la tecnología por operadores establecidos valida su potencial para transformar las operaciones de cosecha y post-cosecha, estableciendo al mismo tiempo un modelo de ingresos recurrentes para CryoMass.

CryoMass Technologies Inc. (OTCQB: CRYM)은 Tribe CollectiveCryoSift Separator™ 생산 모델을 판매했다고 발표했으며, 오클라호마의 대마초 시장에서 Choctaw Processing에 대한 공유 사용 권한이 부여되었습니다. 이 거래에는 두 회사와 함께 최소 5년 동안의 비독점 특허 라이선스 계약이 포함됩니다.

거래 구조는 장비 판매로 인한 일회성 수익과 바이오매스 양에 기반한 반복 처리 수수료를 결합하여 연간 $1,000,000를 초과하는 잠재적 반복 수익을 가능하게 합니다. 이 판매는 NEC Financial Services의 자금 지원을 통해 이루어졌습니다.

이 공유 사용 모델은 CryoMass가 비용 절감과 향상된 추출 효율성을 통해 경쟁 시장 내 여러 운영자에게 가치를 창출할 수 있는 능력을 보여줍니다. 기존 운영자에 의한 기술 채택은 수확 및 후수확 작업을 혁신할 수 있는 잠재력을 검증하며, CryoMass에 대한 반복 수익 모델을 구축합니다.

CryoMass Technologies Inc. (OTCQB: CRYM) a annoncé la vente d'un modèle de production du CryoSift Separator™ à Tribe Collective, avec des droits d'utilisation partagés accordés à Choctaw Processing sur le marché du cannabis en Oklahoma. L'accord comprend des contrats de licence de brevet non exclusifs avec les deux entreprises pour une durée minimale de cinq ans.

La structure de la transaction combine des revenus uniques provenant de la vente d'équipements et des frais de traitement récurrents basés sur le volume de biomasse, avec des revenus récurrents potentiels dépassant 1.000.000 $ par an. La vente a été facilitée par un financement de NEC Financial Services.

Ce modèle d'utilisation partagée démontre la capacité de CryoMass à créer de la valeur pour plusieurs opérateurs au sein de marchés compétitifs en permettant des réductions de coûts et en améliorant l'efficacité d'extraction. L'adoption de la technologie par des opérateurs établis valide son potentiel à transformer les opérations de récolte et de post-récolte tout en établissant un modèle de revenus récurrents pour CryoMass.

CryoMass Technologies Inc. (OTCQB: CRYM) hat den Verkauf eines Produktionsmodells des CryoSift Separator™ an Tribe Collective bekannt gegeben, wobei Choctaw Processing im Oklahoma-Cannabismarkt gemeinsame Nutzungsrechte gewährt wurden. Der Deal umfasst nicht-exklusive Lizenzvereinbarungen für Patente mit beiden Unternehmen für mindestens fünf Jahre.

Die Struktur der Transaktion kombiniert einmalige Einnahmen aus dem Verkauf von Geräten und wiederkehrende Verarbeitungsgebühren, die auf dem Biomassevolumen basieren, mit potenziellen wiederkehrenden Einnahmen von über 1.000.000 $ jährlich. Der Verkauf wurde durch eine Finanzierung von NEC Financial Services ermöglicht.

Dieses Modell der gemeinsamen Nutzung zeigt die Fähigkeit von CryoMass, Wert für mehrere Betreiber in wettbewerbsintensiven Märkten zu schaffen, indem es Kostensenkungen und verbesserte Extraktionseffizienz ermöglicht. Die Technologieadoption durch etablierte Betreiber bestätigt ihr Potenzial, Ernte- und Nachernteoperationen zu transformieren und gleichzeitig ein wiederkehrendes Einnahmemodell für CryoMass zu etablieren.

Positive
  • New equipment sale and licensing deal secured in Oklahoma market
  • Potential recurring revenue exceeding $1M annually
  • Minimum 5-year patent license agreements established
  • Partnership with traditional equipment financing institution (NEC)
Negative
  • Specific financial terms remain confidential
  • Revenue potential depends on uncertain biomass volume

DENVER, Feb. 26, 2025 (GLOBE NEWSWIRE) -- CryoMass Technologies Inc. (the "Company" or "CryoMass") (OTCQB: CRYM), a pioneering leader in cryogenic refinement systems for trichome-rich crops, today announced the sale of an additional CryoSift Separator™ production model ("Unit") to Tribe Collective ("Tribe"), in a transaction in which the usage of the Unit will be shared with Choctaw Processing ("Choctaw"). This sale was executed concurrently with non-exclusive patent license agreements for CryoMass’s patented process with both Tribe and Choctaw, established operators in Oklahoma's cannabis market.

The terms of the agreements include one-time revenue from the sale of the Unit and recurring revenues from processing fees based on biomass volume over the duration of the patent licenses, which are at least five years. While specific terms remain confidential for competitive reasons, recurring revenues to CryoMass in connection with this transaction could exceed $1,000,000 per annum, depending on certain factors. The sale was facilitated through third-party financing provided by NEC Financial Services, LLC a wholly owned subsidiary of NEC Capital Solutions, Limited ("NEC"). CryoMass is grateful to expand its financing partners’ network with the addition of a leading traditional equipment financing institution.

"This innovative transaction demonstrates how our technology can create immediate value for multiple operators within a competitive market," said Christian Noël, CEO of CryoMass. "By enabling significant cost reductions and improved extraction efficiency, our solution provides Tribe and Choctaw with compelling competitive advantages. This shared-usage model could serve as a template for future deployments in other markets where operators seek to enhance their operational efficiency and market position."

CryoMass Partners with Tribe and Choctaw

CryoMass Partners with Tribe and Choctaw

"The CryoSift Separator™ technology represents a significant advancement for our operations," said Ryan Medley, CEO of Tribe. Added Kenny Novotny, CEO of Choctaw, "This processing innovation will be transformative for our business. We look forward to leveraging these capabilities to strengthen our market position."

The execution of this multi-party transaction in Oklahoma demonstrates CryoMass's ability to structure innovative deployment models that address the evolving needs of cannabis operators. As processors and cultivators face increasing market pressures, the adoption of CryoMass's proprietary technology by established companies like Tribe and Choctaw validates its potential to transform both harvest and post-harvest operations that enhance market competitiveness. This transaction advances CryoMass's mission to revolutionize biomass refinement while simultaneously delivering long-term value to customers and establishing a recurring revenue model that supports continued innovation and growth.

The common stock of CryoMass Technologies Inc. trades on the OTC QB market under the symbol CRYM. For further information, please contact the Company by email at investors@cryomass.com or by telephone at 303-222-8092.

About CryoMass
CryoMass Technologies Inc. develops and licenses cutting-edge equipment and processes to refine harvested cannabis, hemp, and other premium crops. The company’s patented technology harnesses liquid nitrogen to reduce biomass and then efficiently isolate, collect and preserve delicate resin glands (trichomes) containing prized compounds like cannabinoids and terpenes.

Building on this technology, CryoMass has engineered its premier Trichome Separation unit (CryoSift Separator™), optimized via patented cryogenic processes to rapidly capture intact, high-value cannabis and hemp trichomes (CryoSift™). Much like sugar and flour refinements, the resulting CryoSift™ concentrate is a superior product compared to unprocessed biomass. For cultivators, reducing biomass into CryoSift™ slashes volume up to 80%, dramatically lowering storage, handling, and transportation costs. Properly stored, CryoSift™ prevents potency and terpene degradation, preserving value. For processors, the minimized input volume also enables considerable cost savings and logistics advantages. Extracting from CryoSift™ using solvents and manufacturing solventless products unlocks industrial scale yields unattainable otherwise. CryoMass anticipates its efficiencies will catalyze industry-wide shifts in cannabis and hemp post-harvest methods. Additionally, the technology shows promise for diverse trichome-rich plants.

About Tribe
Tribe is a vertically integrated cannabis company based in Oklahoma that specializes in crafting innovative cannabis products. Their mission focuses on providing patients with affordable, effective, and distinctive single-source products designed to enhance wellbeing. Tribe distinguishes itself as a comprehensive provider offering diverse product lines while maintaining rigorous standards for quality and consistency without sacrificing the creativity that defines their unique product offerings.

About Choctaw
Choctaw Processing is a leading provider of high-quality manufacturing services dedicated to serving Oklahoma's medical marijuana market. With a focus on excellence and precision, Choctaw Processing specializes in offering customized solutions, including brand manufacturing, packaging, and bulk manufacturing processes. The company's mission is to empower partners by delivering efficient and reliable services while maintaining the highest standards in quality and safety. With the integration of CryoMass technology into their operations, Choctaw Processing looks forward to providing enhanced product quality and optimized services for their manufacturing partners.

This press release is not an offer of securities, or a solicitation for purchase, subscription or sale of securities in the United States of America or in any other jurisdiction in which it would be unlawful to do so.

Forward-looking Statements
This press release may contain forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995 that involve known and unknown risks, uncertainties and other factors, including risk factors identified in the Company's SEC filings, and which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Risks and uncertainties include, without limitation, changes in the regulatory environment affecting the sale and use of cannabis or hemp products and of other, potential lines of businesses that the Company will consider entering at a given time, demand for the Company's products, internal funding and the financial condition of the Company, product roll-out, competition, our dependence upon our commercial partners, variations in the global commodities markets and other commercial matters involving the Company, its products and the markets in which the Company operates or seeks to enter, as well as general economic conditions. The forward-looking statements in this press release are made only as of the date hereof, and unless otherwise required by applicable securities laws, the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. 

Caution Regarding Cannabis Operations in the United States 
Investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in the United States. Marijuana, as defined in the U.S. Controlled Substances Act, remains a Schedule I drug under the respective act, making it illegal under federal law in the U.S. to, among other things, cultivate, distribute or possess cannabis. Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in the U.S. may form the basis for prosecution under applicable U.S. federal money laundering legislation. Please carefully review the Company's SEC filings with respect to related risk factor.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/0d19ee9e-949c-4212-a9d7-55ad4f377e3b


FAQ

What is the potential annual recurring revenue for CryoMass (CRYM) from the Oklahoma deal?

The recurring revenues could exceed $1,000,000 per annum, based on processing fees from biomass volume over the patent license duration.

How long are the patent license agreements for CRYM's cryogenic refinement technology?

The patent license agreements with Tribe and Choctaw are for a minimum of five years.

Who provided the financing for CRYM's CryoSift Separator sale in Oklahoma?

NEC Financial Services, , a subsidiary of NEC Capital Solutions, , provided third-party financing for the transaction.

What are the main benefits of CRYM's CryoSift Separator for cannabis operators?

The technology enables significant cost reductions and improved extraction efficiency, providing operators with competitive advantages in their market.

Cryomass Technologies Inc

OTC:CRYM

CRYM Rankings

CRYM Latest News

CRYM Stock Data

5.35M
199.87M
15.72%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Denver